Mark Pruzanski
2018
Compensation breakdown
| Non-Equity Incentive Plan | $442,260 |
|---|---|
| Option Awards | $1,705,358 |
| Salary | $702,000 |
| Stock Awards | $1,667,718 |
| Other | $8,623 |
| Total | $4,525,960 |
Pruzanski received $1.7M in option awards, accounting for 38% of the total pay in 2018.
Pruzanski also received $442.3K in non-equity incentive plan, $702K in salary, $1.7M in stock awards and $8.6K in other compensation.
Rankings
In 2018, Mark Pruzanski's compensation ranked 2,326th out of 14,244 executives tracked by ExecPay. In other words, Pruzanski earned more than 83.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,326 out of 14,244 | 84th |
Division Manufacturing | 851 out of 5,759 | 85th |
Major group Chemicals And Allied Products | 286 out of 2,122 | 87th |
Industry group Drugs | 230 out of 1,811 | 87th |
Industry Pharmaceutical Preparations | 179 out of 1,385 | 87th |
Pay ratio
| Mark Pruzanski's Pay | $4,525,960 |
|---|---|
| Median Employee's Pay | $244,883 |
| Pay Ratio | 18to 1 |
In 2018, the annual total compensation of Mark Pruzanski was $4,525,960.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $244,883.
The ratio of Mark Pruzanski's pay to the pay of median employee was therefore 18 to one.
Pruzanski's colleagues
We found four more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2018.